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CASE REPORT

Anaesthetic Management of a Young Patient with Homocystinuria
Ali Asghar and Faiza Mazhar Ali

ABSTRACT
Homocystinuria is a rare autosomal recessive genetic disease. It is caused by a deficiency in cystathionine-β-synthase
leading to a defect in methionine metabolism. High levels of plasma homocysteine are associated with vascular injury via
mechanisms of oxidative damage, vascular smooth muscle proliferation, promotion of platelet activation and aggregation,
and disruption of normal procoagulant-anticoagulant balance favouring thrombosis. This is a case of 8 years old boy, a
known case of homocystinuria, who was scheduled for bilateral lensectomy and intraocular lens placement. The major
anaesthetic considerations include the development of thromboembolism, need to avoid nitrous oxide in balanced
anaesthesia regimen and hypoglycaemia.
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INTRODUCTION

CASE REPORT

Homocystinuria is a rare autosomal recessive genetic
disease.1 The incidence of homocystinuria is approximately 1 in 200,000 live births.2 It is due to the deficiency
of the enzyme cystathionine-beta-synthase leading to
accumulation of homocysteine.3 It is generally classified
into three types due to an enzyme deficit at three
different sites associated with the metabolism of the
amino acid methionine. Type-I is caused by a deficiency
of the cofactor pyridoxine (vitamin B6) and the enzyme
cystathionine synthase. Type-II is due to a deficiency of
the enzyme tetrahydrofolate methyltransferase and typeIII is from a defect of the enzyme tetrahydrofolate
reductase.3

An 8 years old boy, known case of homocystinuria
presented with complaint of recurrent headache and
diminished vision. On ophthalmic evaluation, the child
was found to have glaucoma due to bilateral ectopia
lentis, therefore, he was scheduled for bilateral
lensectomy and intraocular lens placement.

High levels of plasma homocysteine are associated with
vascular injury via mechanisms of oxidative damage,
vascular smooth muscle proliferation, promotion of
platelet activation and aggregation, and disruption of
normal procoagulant-anticoagulant balance favouring
thrombosis.3 Symptoms may occur as mildly delayed
development or failure to thrive. Increasing visual
problems may also lead to diagnosis of this condition.
There is no cure for homocystinuria. The conventional
treatment of hyperhomocysteinemia includes folate
supplementation, usually with vitamin B6 or B12. Those
who do not respond will need to eat a low-methionine
diet.4
Better understanding of the disease has lead to better
anaesthetic prognosis in these patients.3 We present
here a case of homocystinuria who underwent surgery
with anaesthetic management.
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On pre- anaesthetic evaluation, he had a past history of
sudden onset of weakness and loss of consciousness
one year back. On workup, he was found to have
extensive dural sinus thrombosis. At that time, he was
placed on warfarin and a CT scan was done after 20
days which showed complete resolution. During that
period extensive workup was done, on which he was
diagnosed as a case of homocystinuria.
On examination, he weighed 25 kilograms and his height
was 130 centimeters. His general physical and systemic
examination including central nervous system examination were normal. The laboratory investigations were
within normal limits except for high levels of serum
homocysteine, which was 120 micromol/litres. In
medication history, he was taking pyridoxine 50 mg BID,
folic acid 5 mg BID, vitamin C 100 mg QD, multivitamin
5 mg QD, acetylsalicylic acid 75 mg QD, betaine 1.5 gm
TID, hydroxocobalamin 1 gm QD and enoxaparin 25 mg
BID.
On the day of surgery, an intravenous infusion of 5%
dextrose was started. The patient was pre-medicated
with syrup midazolam 0.25 mg/kg. After taking the
patients in operating room, standard ASA monitoring
(ECG, NIBP and SpO2) was applied. To prevent
thromboembolism, elastic stocking and automated
pneumatic foot compression system was applied.
General anaesthesia was planned with control mode of
ventilation. Patient was induced with intravenous
propofol 2 mg/kg along with fentanyl 2 ug/kg and
atracurium 0.5 mg/kg. Airway was secured with RAE
tube size 6.0 mm. anaesthesia was maintained with
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isoflurane 2% in 50:50 oxygen and air. Intraoperatively
intravenous infusion of 5% dextrose was continued to
prevent hypoglycaemia as well as blood sugar was
checked which was found to be normal. The patient was
reversed with atropine 0.2 mg/kg and neostigmine 0.05
mg/kg. Duration of surgery was 90 minutes. The
intraoperative course as well as postoperative course of
the patient was uneventful. The patient was discharged
after 3 days.

DISCUSSION
Homocystinuria is an inherited autosomal recessive
disease caused by a deficiency in cystathionine-βsynthase leading to a defect in methionine metabolism.3
Plasma levels of homocysteine are controlled by two
distinct metabolic pathways. Homocysteine may be
salvaged to methionine by remethylation, or degraded to
cysteine by trans-sulfuration.5 Homocysteine may
acquire a methyl group from either N-5-methyltetrahydrofolate (MTHF) or from betaine to reform
methionine. Re-methylation to methionine is catalyzed
by the ubiquitous enzyme, methionine synthase (MS).
This enzyme uses vitamin B12 (methylcobalamin)
as a co-factor, and MTHF as methyl donor. MTHF is
formed from folic acid by the enzyme, 5,10-methylene
tetrahydrofolate reductase (MTHFR). Homocysteine
is diverted to the trans-sulfuration pathway when
methionine concentrations exceed the capacity of the
methionine cycle or when the synthesis of cysteine is
required.5 Cystathionine-β-synthase (CBS) and vitamin
B6 are required for trans-sulfuration.5 CBS catalyzes the
union of homocysteine and serine to form cystathionine.
Cystathionine is hydrolyzed to form cysteine and
ketobutyrate.
Both methionine and homocysteine accumulate in
various tissues as well as in blood and urine. It is a multisystemic disorder of the connective tissue, muscles,
central nervous and cardiovascular systems. Severe
myopia is the first sign of ectopic lentis and may precede
lens dislocation by several months to a year.
There are three major anaesthetic considerations; there
are the development of thromboembolism, avoidance of
nitrous oxide in balanced anaesthesia regimen and
hypoglycaemia.6
Various mechanisms seem to operate to increase the
risk of thromboembolism. These include enhancing
activity of coagulation factors (V, XII), altering the antithrombotic function of endothelium by depressing the
level of anti-thrombotic factors or endothelial derived
nitric oxide, increased platelet adhesiveness, elevated
blood viscosity and mean arterial pressure and
impairment in endothelium mediated platelet inhibition.6
Teng et al. reported a case of homocystinuria, in which
the risk of thromboembolism was minimized by the
administration of low-dose salicylic acid. An elastic
stocking and automated pneumatic foot compression

system, which we used, can also help avoid thromboembolism.7
Nitrous oxide (N2O) should be avoided in the anaesthetic administration as N2O causes increase in the
levels of blood homocysteine by inhibiting methionine
synthase.8 The effect of N2O anaesthesia and postoperative plasma homocysteine levels on myocardial
ischaemia were evaluated in a randomized controlled
trial by Badner et al.8 Patients undergoing carotid end
arterectomy were monitored for ischaemic events with a
three-channel Holter monitor. The investigators found an
association between elevated homocysteine levels and
a significantly increased incidence and duration of
postoperative ischaemia in the patients treated with
N2O.9 In one report, a 40 years old man with a history of
hyperhomocysteinemia had a combined total N2O
exposure of 11 hours during evaluation and management of right lower-limb arterial insufficiency. Four weeks
after exposure to N2O, this patient exhibited severe
sensorimotor deficits that were improved with vitamin B
supplementation.10 Selzer et al. recently reported neurological deterioration and death of a child anaesthetized
twice with nitrous oxide, who was later diagnosed
homocystinuria.2
The mechanism of hypoglycaemia is increased via
methionine leading to increased insulin release resulting
in hypoglycaemia.6 This may be prevented by reducing
the period of fasting, perioperative administration of
intravenous dextrose and monitoring of perioperative
blood sugar levels.
To prevent thromboembolism, enoxaparin, elastic stockings
and intermittent foot compression with a pneumatic
system were used. Careful perioperative management
should be used for this kind of rare metabolic disorder to
prevent serious anaesthetic problems.
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